Can Fite Biopharma Ltd Asset Turnover Ratio (CANF), as of fourth quarter 2025, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Can fite Biopharma Ltd   (NYSE: CANF)
 

Can Fite Biopharma Ltd Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Due to the increase in investments during the fourth quarter 2025, Can Fite Biopharma Ltd 's asset turnover ratio sequentially decreased to 0.02 in the fourth quarter (Dec 31 2025), this is lower than usual.

Within sector 198 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the fourth quarter 2025 compared to the preceding quarter from 3475 to 3901.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CANF Asset Turnover Ratio (Dec 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2024)
IV. Quarter
Y / Y Asset Change 14.14 % 1.54 % -14.49 % 4.32 % 1.07 %
Y / Y Revenue Change -39.91 % - - - -16.79 %
Asset Turnover Ratio (TTM) 0.02 - - - 0.04
CANF's Total Ranking # 3901 # 3475 # # #
Seq. Asset Change 357.65 % 23.24 % -18.86 % -75.06 % 307.11 %
Seq. Revenue Change - - - - -



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 199
Healthcare Sector # 566
Overall Market # 3901

Asset Turnover Ratio Statistics
High Average Low
0.44 0.14 0.04
(Dec 31 2018)   (Dec 31 2021)




CANF Company Profile • Back to CANF Efficiency Comparisons • Compare CANF Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Dec 31 2025, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Dec 31 2025 Assets at quarter ending Dec 31 2025
Prothena Corporation Public Limited Company  0.02 $ 9.684  Millions$ 393.459  Millions
Mangoceuticals Inc   0.02 $ 0.456  Millions$ 18.805  Millions
Uniqure N v   0.02 $ 16.098  Millions$ 725.896  Millions
Ac Immune Sa  0.02 $ 3.573  Millions$ 164.280  Millions
Fate Therapeutics Inc   0.02 $ 6.646  Millions$ 358.228  Millions
Aligos Therapeutics Inc   0.02 $ 2.186  Millions$ 120.926  Millions
Ataibeckley Inc   0.02 $ 4.089  Millions$ 229.383  Millions
Bioxcel Therapeutics Inc   0.02 $ 0.642  Millions$ 38.516  Millions
Aim Immunotech Inc   0.02 $ 0.088  Millions$ 5.413  Millions
Bellevue Life Sciences Acquisition Corp  0.02 $ 2.803  Millions$ 177.123  Millions
Co diagnostics Inc   0.01 $ 0.622  Millions$ 42.775  Millions
Rallybio Corporation  0.01 $ 0.858  Millions$ 59.727  Millions
Prime Medicine Inc   0.01 $ 4.632  Millions$ 333.729  Millions
Absci Corp  0.01 $ 2.800  Millions$ 225.907  Millions
Redhill Biopharma Ltd   0.01 $ 0.286  Millions$ 23.603  Millions
Vivosim Labs Inc   0.01 $ 0.142  Millions$ 12.741  Millions
Silo Pharma Inc  0.01 $ 0.072  Millions$ 6.636  Millions
Atrium Therapeutics Inc   0.01 $ 18.755  Millions$ 1,730.065  Millions
Vyne Therapeutics Inc   0.01 $ 0.533  Millions$ 49.552  Millions
Vistagen Therapeutics Inc   0.01 $ 0.790  Millions$ 79.634  Millions
Clene Inc   0.01 $ 0.200  Millions$ 21.970  Millions
Puretech Health Plc  0.01 $ 4.659  Millions$ 534.710  Millions
Lyra Therapeutics Inc   0.01 $ 0.398  Millions$ 47.177  Millions
Cardiff Oncology Inc   0.01 $ 0.593  Millions$ 71.553  Millions
Cartesian Therapeutics Inc   0.01 $ 2.797  Millions$ 366.777  Millions
Rafael Holdings Inc  0.01 $ 0.770  Millions$ 102.656  Millions
Upstream Bio Inc   0.01 $ 2.854  Millions$ 405.414  Millions
Crinetics Pharmaceuticals Inc   0.01 $ 7.696  Millions$ 1,243.297  Millions
Cuprina Holdings cayman Limited  0.01 $ 0.039  Millions$ 7.079  Millions
Ainos Inc   0.01 $ 0.124  Millions$ 23.456  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.